A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition

Abasian Maryam; Pour Shahbaz Abbas; Abasian Mahboubeh; Saffarian Zahra; Abasi Imane; Abasian Masoumeh

doi:doi:10.11648/j.ajap.20150403.13

| Peer-Reviewed

A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition

Abasian Maryam, Pour Shahbaz Abbas, Abasian Mahboubeh, Saffarian Zahra, Abasi Imane, Abasian Masoumeh

Published in American Journal of Applied Psychology (Volume 4, Issue 3)

Received: 10 April 2015 Accepted: 17 April 2015 Published: 6 May 2015

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The first group of psychiatric treatments for children with attention deficit/hyperactivity disorder (ADHD) is stimulant drug such as methylphenidate. The aim of this study is investigating cognitive profile in ADHD children who are using medicated treatment and no medicated treatment, in WISC IV. Participants are 29 ADHD children (13 no medicated and 16 medicated) and 25 normal children. The sampling method is convenient. Children were 7 to 12 years old. Result showed significant differences between ADHD group who uses medication and those who don’t, and normal and ADHD groups who don’t use medication in verbal comprehension and processing indexes. In perceptual reasoning index, there was significant difference between normal group and ADHD group in using medication, also in working memory index there were no significant differences between ADHD groups (with and without medication use). Using medical treatment and changing in the process of disorder toward normal function in children with ADHD following it, can be an evidence of neurological problems in these children.

Published in	American Journal of Applied Psychology (Volume 4, Issue 3)
DOI	10.11648/j.ajap.20150403.13
Page(s)	61-65
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2015. Published by Science Publishing Group

Keywords

Attention Deficit/ Hyperactivity Disorder, Medicated, No Medicated, WISC-IV

References

[1]	Association, American Psychiatric. (2000). DSM-IV-TR: Diagnostic and statistical manual of mental disorders, text revision: American Psychiatric Association.
[2]	Barkley, Russell A. (1997). Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychological bulletin, 121(1), 65.
[3]	Barkley, Russell A. (2005). Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (Vol. 1): Guilford Press.
[4]	Barkley, Russell A, DuPaul, George J, & McMurray, Mary B. (1990). Comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria. Journal of consulting and clinical psychology, 58(6), 775.
[5]	Barkley, Russell A, Grodzinsky, Gail, & DuPaul, George J. (1992). Frontal lobe functions in attention deficit disorder with and without hyperactivity: A review and research report. Journal of abnormal child psychology, 20(2), 163-188.
[6]	Bedard, Anne-Claude, Martinussen, Rhonda, Ickowicz, Abel, & Tannock, Rosemary. (2004). Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 43(3), 260-268.
[7]	Biederman, Joseph, Mick, Eric, & Faraone, Stephen V. (2000). Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. American journal of psychiatry, 157(5), 816-818.
[8]	Bowers, Thomas G, Risser, Marcia G, Suchanec, John F, Tinker, Dorris E, Ramer, Jeanette C, & Domoto, Mark. (1992). A Developmental Index Using the Wechsler Intelligence Scale for Children Implications for the Diagnosis and Nature of ADHD. Journal of learning disabilities, 25(3), 179-185.
[9]	Brown, Michael B. (2000). Diagnosis and treatment of children and adolescents with Attention‐Deficit/Hyperactivity Disorder. Journal of Counseling & Development, 78(2), 195-203.
[10]	Conners, CK, March, JS, Frances, A, Wells, KC, & Ross, R. (2001). The Expert Consensus Guideline Series: treatment of attention-deficit/hyperactivity disorder. J Atten Disord, 4(suppl 1), S1-S128.
[11]	Dophide, J. (2001). ADHD part I: Current status, diagnosis, etiology/ pathphysiology [APhA annual meeting therapeutic updates part I]. American Pharmaceutical Association 48th Annual Meeting.
[12]	Faraone, Stephen V, Spencer, Thomas, Aleardi, Megan, Pagano, Christine, & Biederman, Joseph. (2004). Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. Journal of clinical psychopharmacology, 24(1), 24-29.
[13]	Gaub, Miranda, & Carlson, Caryn L. (1997). Behavioral characteristics of DSM-IV ADHD subtypes in a school-based population. Journal of abnormal child psychology, 25(2), 103-111.
[14]	Goodyear, Patricia, & Hynd, George W. (1992). Attention-deficit disorder with (ADD/H) and without (ADD/WO) hyperactivity: Behavioral and neuropsychological differentiation. Journal of Clinical Child and Adolescent Psychology, 21(3), 273-305.
[15]	Hale, James B, & Fiorello, Catherine A. (2004). School neuropsychology: A practitioner's handbook: Guilford Press.
[16]	Homer, CJ, Baltz, RD, Hickson, GB, Miles, PV, Newman, TB, Shook, JE, . . . Goldberg, MJ. (2000). Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics, 105(5), 1158-1170.
[17]	International Consensus Statement on ADHD. (2002). Clin Child Fam Psychol Rev, 5, 89-111.
[18]	Mehta, Mitul A, Goodyer, Ian M, & Sahakian, Barbara J. (2004). Methylphenidate improves working memory and set‐shifting in AD/HD: relationships to baseline memory capacity. Journal of Child Psychology and Psychiatry, 45(2), 293-305.
[19]	Pelham, W. E., & Milich, R. (1999). Individual differences in response to ritalin in classwork and social behavior. In B. B. O. L. L. Greenhill (Ed.), Ritalin: Theory and patient management (pp. 203-221): New York: Mary Ann Liebert.
[20]	Prifitera, Aurelio, & Dersh, Jeffrey. (1993). Base rates of WISC-III diagnostic subtest patterns among normal, learning-disabled, and ADHD samples.
[21]	Rhodes, Sinéad M, Coghill, David R, & Matthews, Keith. (2006). Acute neuropsychological effects of methylphenidate in stimulant drug‐naïve boys with ADHD II–broader executive and non‐executive domains. Journal of Child Psychology and Psychiatry, 47(11), 1184-1194.
[22]	Rucklidge, Julia J, & Tannock, Rosemary. (2001). Psychiatric, psychosocial, and cognitive functioning of female adolescents with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 40(5), 530-540.
[23]	Sadeghi, A., Rabie, M.and Abedi, M.R. (2012). Reliability and Validation of Wechsler Intelligence Scale for Children-fourth edition. Journal of Developmental Psychology, 7(28), 47-55.
[24]	Sykes, Donald H, Douglas, Virginia I, & Morgenstern, Gert. (1973). Sustained attention in Hyperactive Children*. Journal of Child Psychology and Psychiatry, 14(3), 213-220.
[25]	Tannock, Rosemary, Ickowicz, Abel, & Schachar, Russell. (1995). Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. Journal of the American Academy of Child & Adolescent Psychiatry, 34(7), 886-896.
[26]	Tiholov, Tihol T, Zawallich, Andre, & Janzen, Henry L. (1996). Diagnosis based on the WISC-III processing speed factor. Canadian Journal of School Psychology, 12(1), 23-34.
[27]	Valdizán, JR, & Izaguerri-Gracia, AC. (2009). Trastorno por déficit de atención/hiperactividad en adultos. Rev Neurol, 48(Supl 2), S95-99.
[28]	Wechsler, David. (2003). Wechsler intelligence scale for children–Fourth Edition (WISC-IV). San Antonio, TX: The Psychological Corporation.
[29]	Weiler, Michael D, Bernstein, Jane Holmes, Bellinger, David C, & Waber, Deborah P. (2000). Processing speed in children with attention deficit/hyperactivity disorder, inattentive type. Child Neuropsychology, 6(3), 218-234.
[30]	Weiler, Michael David, Bernstein, Jane Holmes, Bellinger, David, & Waber, Deborah P. (2002). Information processing deficits in children with attention-deficit/hyperactivity disorder, inattentive type, and children with reading disability. Journal of learning disabilities, 35(5), 449-462.

Cite This Article

Plain Text BibTeX RIS

APA Style

Abasian Maryam, Pour Shahbaz Abbas, Abasian Mahboubeh, Saffarian Zahra, Abasi Imane, et al. (2015). A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition. American Journal of Applied Psychology, 4(3), 61-65. https://doi.org/10.11648/j.ajap.20150403.13

Copy | Download

ACS Style

Abasian Maryam; Pour Shahbaz Abbas; Abasian Mahboubeh; Saffarian Zahra; Abasi Imane, et al. A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition. Am. J. Appl. Psychol. 2015, 4(3), 61-65. doi: 10.11648/j.ajap.20150403.13

Copy | Download

AMA Style

Abasian Maryam, Pour Shahbaz Abbas, Abasian Mahboubeh, Saffarian Zahra, Abasi Imane, et al. A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition. Am J Appl Psychol. 2015;4(3):61-65. doi: 10.11648/j.ajap.20150403.13

Copy | Download

@article{10.11648/j.ajap.20150403.13,
  author = {Abasian Maryam and Pour Shahbaz Abbas and Abasian Mahboubeh and Saffarian Zahra and Abasi Imane and Abasian Masoumeh},
  title = {A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition},
  journal = {American Journal of Applied Psychology},
  volume = {4},
  number = {3},
  pages = {61-65},
  doi = {10.11648/j.ajap.20150403.13},
  url = {https://doi.org/10.11648/j.ajap.20150403.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajap.20150403.13},
  abstract = {The first group of psychiatric treatments for children with attention deficit/hyperactivity disorder (ADHD) is stimulant drug such as methylphenidate. The aim of this study is investigating cognitive profile in ADHD children who are using medicated treatment and no medicated treatment, in WISC IV. Participants are 29 ADHD children (13 no medicated and 16 medicated) and 25 normal children. The sampling method is convenient. Children were 7 to 12 years old. Result showed significant differences between ADHD group who uses medication and those who don’t, and normal and ADHD groups who don’t use medication in verbal comprehension and processing indexes. In perceptual reasoning index, there was significant difference between normal group and ADHD group in using medication, also in working memory index there were no significant differences between ADHD groups (with and without medication use). Using medical treatment and changing in the process of disorder toward normal function in children with ADHD following it, can be an evidence of neurological problems in these children.},
 year = {2015}
}

Copy | Download

TY  - JOUR
T1  - A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition
AU  - Abasian Maryam
AU  - Pour Shahbaz Abbas
AU  - Abasian Mahboubeh
AU  - Saffarian Zahra
AU  - Abasi Imane
AU  - Abasian Masoumeh
Y1  - 2015/05/06
PY  - 2015
N1  - https://doi.org/10.11648/j.ajap.20150403.13
DO  - 10.11648/j.ajap.20150403.13
T2  - American Journal of Applied Psychology
JF  - American Journal of Applied Psychology
JO  - American Journal of Applied Psychology
SP  - 61
EP  - 65
PB  - Science Publishing Group
SN  - 2328-5672
UR  - https://doi.org/10.11648/j.ajap.20150403.13
AB  - The first group of psychiatric treatments for children with attention deficit/hyperactivity disorder (ADHD) is stimulant drug such as methylphenidate. The aim of this study is investigating cognitive profile in ADHD children who are using medicated treatment and no medicated treatment, in WISC IV. Participants are 29 ADHD children (13 no medicated and 16 medicated) and 25 normal children. The sampling method is convenient. Children were 7 to 12 years old. Result showed significant differences between ADHD group who uses medication and those who don’t, and normal and ADHD groups who don’t use medication in verbal comprehension and processing indexes. In perceptual reasoning index, there was significant difference between normal group and ADHD group in using medication, also in working memory index there were no significant differences between ADHD groups (with and without medication use). Using medical treatment and changing in the process of disorder toward normal function in children with ADHD following it, can be an evidence of neurological problems in these children.
VL  - 4
IS  - 3
ER  -

Copy | Download

Author Information

Abasian Maryam

Clinical psychology, faculty of humanities, Sari Islamic Azad University, Sari, Iran
Pour Shahbaz Abbas

Clinical psychology, clinical psychology department, Rehabilitation and Social Welfare University, Tehran, Iran
Abasian Mahboubeh

Clinical psychology, clinical psychology department, Rehabilitation and Social Welfare University, Tehran, Iran
Saffarian Zahra

Clinical psychology, clinical psychology department, Rehabilitation and Social Welfare University, Tehran, Iran
Abasi Imane

Clinical psychology, clinical psychology department, Rehabilitation and Social Welfare University, Tehran, Iran
Abasian Masoumeh

Medical school, Shahrood Islamic Azad University, Shahrood, Iran

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Abasian Maryam, Pour Shahbaz Abbas, Abasian Mahboubeh, Saffarian Zahra, Abasi Imane, et al. (2015). A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition. American Journal of Applied Psychology, 4(3), 61-65. https://doi.org/10.11648/j.ajap.20150403.13

Copy | Download

ACS Style

Abasian Maryam; Pour Shahbaz Abbas; Abasian Mahboubeh; Saffarian Zahra; Abasi Imane, et al. A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition. Am. J. Appl. Psychol. 2015, 4(3), 61-65. doi: 10.11648/j.ajap.20150403.13

Copy | Download

AMA Style

Abasian Maryam, Pour Shahbaz Abbas, Abasian Mahboubeh, Saffarian Zahra, Abasi Imane, et al. A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition. Am J Appl Psychol. 2015;4(3):61-65. doi: 10.11648/j.ajap.20150403.13

Copy | Download

@article{10.11648/j.ajap.20150403.13,
  author = {Abasian Maryam and Pour Shahbaz Abbas and Abasian Mahboubeh and Saffarian Zahra and Abasi Imane and Abasian Masoumeh},
  title = {A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition},
  journal = {American Journal of Applied Psychology},
  volume = {4},
  number = {3},
  pages = {61-65},
  doi = {10.11648/j.ajap.20150403.13},
  url = {https://doi.org/10.11648/j.ajap.20150403.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajap.20150403.13},
  abstract = {The first group of psychiatric treatments for children with attention deficit/hyperactivity disorder (ADHD) is stimulant drug such as methylphenidate. The aim of this study is investigating cognitive profile in ADHD children who are using medicated treatment and no medicated treatment, in WISC IV. Participants are 29 ADHD children (13 no medicated and 16 medicated) and 25 normal children. The sampling method is convenient. Children were 7 to 12 years old. Result showed significant differences between ADHD group who uses medication and those who don’t, and normal and ADHD groups who don’t use medication in verbal comprehension and processing indexes. In perceptual reasoning index, there was significant difference between normal group and ADHD group in using medication, also in working memory index there were no significant differences between ADHD groups (with and without medication use). Using medical treatment and changing in the process of disorder toward normal function in children with ADHD following it, can be an evidence of neurological problems in these children.},
 year = {2015}
}

Copy | Download

TY  - JOUR
T1  - A Comparison of the Cognitive Profiles of Children with Attention Deficit/Hyperactivity Disorder Receiving Pharmacotherapy and Those Not Receiving Pharmacotherapy in Wechsler Intelligence Scales-Forth Edition
AU  - Abasian Maryam
AU  - Pour Shahbaz Abbas
AU  - Abasian Mahboubeh
AU  - Saffarian Zahra
AU  - Abasi Imane
AU  - Abasian Masoumeh
Y1  - 2015/05/06
PY  - 2015
N1  - https://doi.org/10.11648/j.ajap.20150403.13
DO  - 10.11648/j.ajap.20150403.13
T2  - American Journal of Applied Psychology
JF  - American Journal of Applied Psychology
JO  - American Journal of Applied Psychology
SP  - 61
EP  - 65
PB  - Science Publishing Group
SN  - 2328-5672
UR  - https://doi.org/10.11648/j.ajap.20150403.13
AB  - The first group of psychiatric treatments for children with attention deficit/hyperactivity disorder (ADHD) is stimulant drug such as methylphenidate. The aim of this study is investigating cognitive profile in ADHD children who are using medicated treatment and no medicated treatment, in WISC IV. Participants are 29 ADHD children (13 no medicated and 16 medicated) and 25 normal children. The sampling method is convenient. Children were 7 to 12 years old. Result showed significant differences between ADHD group who uses medication and those who don’t, and normal and ADHD groups who don’t use medication in verbal comprehension and processing indexes. In perceptual reasoning index, there was significant difference between normal group and ADHD group in using medication, also in working memory index there were no significant differences between ADHD groups (with and without medication use). Using medical treatment and changing in the process of disorder toward normal function in children with ADHD following it, can be an evidence of neurological problems in these children.
VL  - 4
IS  - 3
ER  -

Copy | Download